Today, I had the privilege of presenting Calla Lily Clinical Care’s latest innovation, Callavid®, at the MidAtlantic Capital Conference with PACT in Philadelphia. It’s an exciting step forward in women’s health, particularly for those navigating the challenges of IVF and miscarriage.

Our Callavid technology harnesses the power of intravaginal drug delivery initially through our medical device impregnated with progesterone. By doing this, we take the pain out of IVF, reduce the uncertainty of medication administration, and dramatically improve both comfort and compliance.

Sharing Calla Lily’s story and my personal journey with IVF today has been incredibly meaningful. This work isn’t just a professional mission—it’s deeply personal. I’m thrilled to be part of a movement that supports women’s health in ways that matter.